EurekAlert!2d
New technique to measure circulating tumor DNA in metastatic cancer may improve disease progression surveillance and patient outcomes
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumor DNA (ctDNA) may be critical.
Hosted on MSN1mon
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment ...
Hosted on MSN1mon
Genomic Classifier Tests Play Heterogeneous Role in Prostate Cancer Risk Classification
TUESDAY, Jan. 21, 2025 (HealthDay News) -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk classification or treatment ...
AZOM7y
Mikro ACM Air Classifier Mill from Hosokawa Micron
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure The Mikro ACM air classifier mill ...
ascopubs.org8d
A non-coding RNA based classifier for favorable outcomes in clinically organ confined bladder cancer.
Impact of variant allele frequency (VAF) of TP53 alterations and Signatera circulating tumor DNA (ctDNA) monitoring for patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab ...
UroToday12d
ASCO GU 2025: Decipher Genomic Classifier of Early Prostate Cancer and Underlying Transcriptomic Profile: American Versus Non-American
Using the Decipher GC database (Decipher Biosciences Inc), the study investigators identified Israeli (non-American) versus matched American patients with early prostate cancer. Matching was performed ...